Discover

GLP
Global Partners LP
47.41
200 x undefined
100 x undefined
bid
ask
+
0.82
1.76%
150 @ 04:00 PM
46.49 -0.92 (1.94%)
Ytd13.29%
1y-8.19%
46.59
day range
47.43
39.58
52 week range
53.25
Open46.55Prev Close46.59Low46.59High47.43Mkt Cap1.61B
Vol89.60KAvg Vol92.52KEPS3.60P/E13.17Forward P/E18.89
Beta1.01Short Ratio2.51Inst. Own50.34%Dividend3.06Div Yield6.57
Ex Div Date05-11Earning08-0650-d Avg47.59200-d Avg46.061yr Est45.50

GLP News

Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results
fxempire.com
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results

Eli Lilly and Company (LLY) shares up 18,585% since Big Money bought big in 1990.

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified wa

Viking Therapeutics: Updating Pipeline Potential As Oral GLP‑1s Accelerate
seekingalpha.com
Viking Therapeutics: Updating Pipeline Potential As Oral GLP‑1s Accelerate

Viking Therapeutics, Inc. maintains a Hold rating, reflecting a balanced risk-reward at its current

Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters?
zacks.com
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters?

LLY is expanding its revenue base beyond Mounjaro and Zepbound with new launches and label expansion

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
globenewswire.com
Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

Weight Watchers expands access for Med+ Medicare beneficiaries to GLP-1 medications covered by the M

Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years
fool.com
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years

Eli Lilly could capitalize on the growing GLP-1 market and deliver strong returns through 2031. Howe

Global Partners LP Announces Full Redemption of Series B Fixed Rate Cumulative Redeemable Perpetual Preferred Units
businesswire.com
Global Partners LP Announces Full Redemption of Series B Fixed Rate Cumulative Redeemable Perpetual

WALTHAM, Mass.--(BUSINESS WIRE)--Global Partners LP (NYSE: GLP) (“Global”) today announced that it i

Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up
proactiveinvestors.co.uk
Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up

Citi has said Novo Nordisk's (NYSE:NVO) Wegovy pill is outpacing its rivals in the United States, ev

CVS Just Turned Its 9,000 Pharmacies Into a GLP-1 Delivery Machine. 1 Top Wall Street Analyst Thinks That's a Reason to Buy the Stock
fool.com
CVS Just Turned Its 9,000 Pharmacies Into a GLP-1 Delivery Machine. 1 Top Wall Street Analyst Thinks

CVS Health announced a program to help patients get easier access to GLP-1 medicines. This initiativ

GLP-1s linked to smell and taste impairment in diabetes patients
reuters.com
GLP-1s linked to smell and taste impairment in diabetes patients

We also report on a potentially simple solution to ​nausea experienced by cancer patients receiving

Lexaria's Human Study GLP-1-H26-7 has Begun Dosing on Schedule
thenewswire.com
Lexaria's Human Study GLP-1-H26-7 has Begun Dosing on Schedule

Kelowna, British Columbia – June 25, 2026 - TheNewswire – Lexaria Bioscience Corp. (Nasdaq: LEXX) (t

Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications
businesswire.com
Walgreens Pharmacists Help Medicare Patients Navigate New Access to GLP‑1 Medications

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is supporting the more than 56 million patients in the M